The European Paediatric Formulation Initiative (EuPFI) works to improve the preparation of better and safer medicines for children. One area they are interested in is the “gadgets” or devices (e.g. measuring spoons, dosing cups, inhalers) that are used to help...
The Multi-regional Clinical Trials Center of Brigham (MRCT) in collaboration with Harvard Catalyst have developed a series of COVID-19 clinical research handouts that can be used as general informative material to prepare potential participants in advance of...
The Food and Drug Administration has announced the launch of a docket to require inputs and comments from patients, patient advocates, the scientific community, health professionals, regulatory and health authorities and general public regarding practical steps to...
On May 14-16th over 1,500 people from 57 different countries, representing all stakeholder groups in the rare disease community, joined together at the 10th European Conference of Rare Diseases & Orphan Products — ECRD 2020. EPTRI, an EU-funded project coordinated...
International Clinical Trials Day is held on 20 May each year since 2005 to commemorate the day that James Lind began his famous trial for the scurvy. The objective is to make this moment a focal point for international communication events, meetings, debates, and...
The Committee on Bioethics (DH-BIO) - Council of Europe released “DH-BIO Statement on human rights considerations relevant to the COVID-19 pandemic”, recalling the fundamental principles, based on the respect for human dignity and human rights, which must guide...
We are happy to announce the publication on the European Pharmaceutical Law Review, special issue on AI in the pharmaceutical field. Among authors are Annagrazia Altavilla, Viviana Giannuzzi, Annalisa Landi and Adriana Ceci, members of the TEDDY Working Group on...
In occasion of the 16th Meeting of the Committee on Bioethics (DH -BIO) held on 19-21 November 2019, the Strategic Action Plan on Human Rights and Technologies in Biomedicine has been adopted for the period 2020-2025. The vision and approach of the Strategic Action...
We are happy to announce that the article “Different Strategies to Execute Multi-Database Studies for Medicines Surveillance in Real-World Setting: A Reflection on the European Model” was published on Clinical Pharmacology & Therapeutics Journal. The publication...
We are happy to present you the last novelty on TEDDY identity and governance. A new statute, indeed, has been approved by its associated members, foreseeing novelties in TEDDY identity and governance. The first news is related to the mission, oriented towards an...